Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Skin, Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT04616248
What this trial is testing

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more
University of Southern California 14
Early research (Phase 1)Study completedNCT04323202
What this trial is testing

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Who this might be right for
Basal Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center 13
Not applicableUnknownNCT05698706
What this trial is testing

High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Jacek Calik 27
Not applicableEnded earlyNCT03370861
What this trial is testing

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

Who this might be right for
AutoimmunityMelanomaMerkel Cell Carcinoma+3 more
Washington University School of Medicine 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04928222
What this trial is testing

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

Who this might be right for
Basal Cell Carcinoma
SkinJect, Inc. 25
Not applicableStudy completedNCT00099112
What this trial is testing

Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II

Who this might be right for
Non-melanomatous Skin CancerPrecancerous Condition
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00783965
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Who this might be right for
Skin Carcinoma
UCSF Benioff Children's Hospital Oakland 34
Testing effectiveness (Phase 2)Study completedNCT00489086
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Who this might be right for
Neoplastic Syndrome
UCSF Benioff Children's Hospital Oakland 36
Testing effectiveness (Phase 2)UnknownNCT04679480
What this trial is testing

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

Who this might be right for
Basal Cell Carcinoma
Reinhard Dummer 20
Not applicableUnknownNCT04805905
What this trial is testing

A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study

Who this might be right for
Skin Cancer, Basal CellSkin CancerSkin Cancer, Non-Melanoma+2 more
McMaster University 30
Not applicableStudy completedNCT02310503
What this trial is testing

Spanish Registry of Mohs Surgery

Who this might be right for
Skin NeoplasmsCarcinoma, Basal CellCarcinoma, Squamous Cell+4 more
Fundación Academia Española de Dermatología 6,000
Post-approval studies (Phase 4)Study completedNCT00204555
What this trial is testing

Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
University Hospital Tuebingen 100
Early research (Phase 1)Study completedNCT04925713
What this trial is testing

IFx-Hu2.0 for the Treatment of Patients With Skin Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
TuHURA Biosciences, Inc. 5
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)UnknownNCT05329792
What this trial is testing

L19IL2/L19TNF in Skin Cancer Patients

Who this might be right for
BCC - Basal Cell CarcinomaSCC - Squamous Cell CarcinomaMerkel Cell Carcinoma+4 more
Philogen S.p.A. 70
Not applicableNot Yet RecruitingNCT06273722
What this trial is testing

D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study

Who this might be right for
Basal Cell CarcinomaOptical Coherence Tomography
Maastricht University Medical Center 424
Testing effectiveness (Phase 2)Study completedNCT00002975
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin CancerPrecancerous Condition
Roswell Park Cancer Institute 180
Testing effectiveness (Phase 2)Study completedNCT01543581
What this trial is testing

Vismodegib for Treatment of Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Abel Torres, MD 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020912
What this trial is testing

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Who this might be right for
Basal Cell Carcinoma
Case Comprehensive Cancer Center 18
Next Page